Dr Edward Bataillard

Dr Edward Bataillard studied biochemistry at Cambridge University, and graduated in medicine from Oxford University. He completed his internal medical training in North West London, followed by specialist training in Haematology under Imperial College. As part of his training, he undertook an industry research fellowship focusing on Lymphoma clinical trials, as well as a fellowship in Stem Cell Transplantation (BMT coordinator) at Hammersmith Hospital. His areas of expertise include Lymphoma and lymphocytic leukaemia, CAR-T cell therapy, stem cell transplantation and general Haematology. Dr Bataillard is committed to advancing the field of Haematology and providing compassionate, cutting-edge care to his patients.

Harris W, Bataillard EJ, Choi Y, El-Galaly TC, Cuchelkar V, Henneges C, Kwan A, Schneider DJ, Paulson JN, Nielsen TG. TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma. JCO Clin Cancer Inform. 2022 Jan;6:e2100121. doi: 10.1200/CCI.21.00121. PMID: 35044836.

Bataillard EJ, Cheah CY, Maurer MJ, Khurana A, Eyre TA, El-Galaly TC. Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review. Blood Adv. 2021 May 11;5(9):2426-2437. doi: 10.1182/bloodadvances.2021004665. PMID: 33961018; PMCID: PMC8114545.